A requirement for NF-protocadherin and TAF1/Set in cell adhesion and neural tube formation  by Rashid, Dana et al.
91 (2006) 170–181
www.elsevier.com/locate/ydbioDevelopmental Biology 2A requirement for NF-protocadherin and TAF1/Set in cell adhesion and
neural tube formation
Dana Rashid, Katie Newell, Leah Shama, Roger Bradley ⁎
Department of Cell Biology and Neuroscience, Montana State University, Bozeman, MT 59717, USA
Received for publication 4 June 2005; revised 1 December 2005; accepted 12 December 2005
Available online 19 January 2006Abstract
Neurulation in vertebrates is an intricate process requiring extensive alterations in cell contacts and cellular morphologies as the cells in the
neural ectoderm shape and form the neural folds and neural tube. Despite these complex interactions, little is known concerning the molecules that
mediate cell adhesion within the embryonic neural plate and neural folds. Here, we demonstrate the requirement for NF-protocadherin (NFPC) and
its cytosolic partner TAF1/Set for proper neurulation in Xenopus. Both NFPC and TAF1 function in cell–cell adhesion in the neural ectoderm, and
disruptions in either NFPC or TAF1 result in a failure of the neural tube to close. This neural tube defect can be attributed to a lack of proper
organization of the cells in the dorsal neural folds, manifested by a loss in the columnar epithelial morphology and apical localization of F-actin.
However, the epidermal ectoderm is still able to migrate and cover the open neural tube, indicating that the fusions of the neural tube and
epidermis are separate events. These studies demonstrate that NFPC and TAF1 function to maintain proper cell–cell interactions within the neural
folds and suggest that NFPC and TAF1 participate in novel adhesive mechanisms that contribute to the final events of vertebrate neurulation.
© 2005 Elsevier Inc. All rights reserved.Keywords: Xenopus; Protocadherin; NeurulationIntroduction
One of the crucial early events in the development of the
vertebrate nervous system is the process of neurulation: the
formation of the neural tube from an initially flat and uniform
neural plate. This is a complex and highly coordinated
progression in which the neural folds form, rise out of the
plane of the embryo, and fuse along the dorsal midline. This
process involves both coordinated cell shape changes and
cellular migrations as the cells of the neural epithelium
rearrange to shape the neural tube (Colas and Schoenwolf,
2001). In the frog Xenopus, neurulation begins with the
induction of the neural plate from the dorsal ectoderm (De
Robertis and Kuroda, 2004). The neural ectoderm cells then
undergo convergent–extension (CE) to narrow the neural plate
mediolaterally, while simultaneously lengthening along the
anterior–posterior (AP) axis (Elul et al., 1997; Poznanski et al.,
1997; Davidson and Keller, 1999; Wallingford et al., 2002). As⁎ Corresponding author.
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doi:10.1016/j.ydbio.2005.12.027the embryo undergoes CE, the cells in the medial regions of the
neural plate constrict along their apical side to become wedge-
shaped hinge point cells, which results in the bending and
elevation of the lateral neural plate to form the neural folds.
Further elevation of the neural folds is thought to require
continued CE of cells in the lateral neural plate, providing the
force necessary to propel the folds towards the midline, and the
formation of new dorsal–lateral hinge point cells, which bends
the neural folds toward the midline (Davidson and Keller, 1999;
Haigo et al., 2003). Once in apposition the neural folds fuse, and
the neural and epidermal ectoderm segregate from one another
to give rise to the neural tube and its epidermal covering. Thus,
in Xenopus, intrinsic processes required for neurulation include
coordinated cell shape changes, cell migration and cell
intercalation, all of which necessitate regulated cell–cell
adhesion.
While the morphological events contributing to neural tube
formation have been well studied, the molecular events that
control neurulation are less well understood. Recent evidence
has implicated members of the planar cell polarity (PCP)
pathway, together with proteins that modify the actin
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folds (Goto and Keller, 2002; McNeill, 2002; Wallingford et al.,
2002; Wallingford and Harland, 2002; Haigo et al., 2003;
Lawrence and Morel, 2003; Zohn et al., 2003). However, little
is known concerning the molecules that mediate cell–cell
adhesion during the formation and fusion of the neural folds.
Among the likely candidate molecules are members of the
cadherin family of cell adhesion proteins. Cadherins are a large
family of calcium-dependent transmembrane proteins that are
localized to sites of cell–cell contact (Koch et al., 1999; Angst et
al., 2001; Frank and Kemler, 2002; Goodwin and Yap, 2005).
Cadherin family members are known to mediate cell–cell
adhesion during tissue morphogenesis throughout development,
including during formation of the early nervous system (Tepass,
1999; Vleminckx and Kemler, 1999; Redies, 2000; Tepass et
al., 2000; Gumbiner, 2005). For example, the classical
cadherins E- and N-cadherin are required for the proper
segregation of the ectoderm into neural and epidermal
components after neural tube closure (Detrick et al., 1990;
Kintner, 1992; Levine et al., 1994), and null mutations in N-
cadherin result in animals with impaired neural tube develop-
ment (Radice et al., 1997; Luo et al., 2001; Lele et al., 2002). In
addition, cadherin members are known to be involved in later
events in neural development, including neural crest migration
and the segregation of motor neurons into pools (Nakagawa and
Takeichi, 1995; Nakagawa and Takeichi, 1998; Borchers et al.,
2001; Price et al., 2002). Thus, while cadherins play key roles in
the later events of neural tube formation and differentiation, a
role for cadherin-mediated cell adhesion in early events in
neurulation, particularly the organization and fusion of the
neural folds, has yet to be described.
In Xenopus, a candidate molecule for mediating the adhesive
events in the neural folds is NF-protocadherin (NFPC). NFPC
exhibits a restricted expression pattern in early embryos, where
it is primarily localized to the tips of the neural folds, just prior
to neural fold fusion, as well as to the deep or sensorial layer of
the embryonic ectoderm (Bradley et al., 1998). Ectopic
expression studies have previously shown that NFPC functions
as a potent cell adhesion molecule in the embryonic ectoderm,
where it interacts with the cellular co-factor TAF1/Set, and that
both NFPC and TAF1 are necessary for the formation of the
embryonic ectoderm in vivo (Bradley et al., 1998; Heggem and
Bradley, 2003). The expression of NFPC in the neural folds,
together with the ability of NFPC and TAF1 to mediate cell
adhesion, suggests additional roles for these molecules in the
formation and/or closure of the neural folds; however, this has
not yet been addressed. In this report, we demonstrate that
NFPC and TAF1 mediate cell adhesion within the neural folds
and that both are required for proper neurulation in Xenopus.
Disruptions in either NFPC or TAF1 result in a failure of the
neural tube to close along the entire anterior–posterior axis.
While neither NFPC nor TAF1 are required for initial formation
or elevation of the neural folds, both are essential for the proper
organization of the neural folds prior to neural tube closure.
These results suggest that NFPC and TAF1 have interrelated
roles in the adhesive events that precede the fusion of the neural
folds in Xenopus.Materials and methods
Constructs and injections
NFPC, NFΔE, and TAF1 constructs and antisense morpholinos were as
previously described (Heggem and Bradley, 2003). TAF1 C-terminal (TAF1ΔC)
and N-terminal (TAF1ΔN) deletion constructs were generated by PCR and
subcloned into pCS2MT (Turner and Weintraub, 1994). Synthesis and injection
of RNA or morpholinos were performed as described (Heggem and Bradley,
2003). For NTDs, approximately 2 pM of morpholino was injected into a single
dorsal blastomere at the 8–16 cell stage, together with 100 pg LacZ mRNA to
mark the site of injection. Similarly, for dominant-negative experiments,
approximately 500 pg NFΔE, TAF1ΔN, or TAF1ΔC RNA was injected into a
single dorsal blastomere. For rescue experiments, NFPCMO, TAF1MO, NFDE,
or TAF1ΔN RNAwas injected as above, along with 2 ng NFPC or TAF1mRNA
respectively. Embryos were fixed at the indicated stages and stained for β-
galactosidase activity with X-Gal as previously described (Bradley et al., 1998).
In situ hybridizations and histology
In situ hybridizations were performed according to standard protocols
(Harland, 1991). cDNA probes for NFPC and TAF1 and the anti-NFPC antibody
were as described (Bradley et al., 1998; Heggem and Bradley, 2003). For NFPC
and TAF1 double staining, stage 17 embryos were fixed in MEMFA (100 mM
MOPS, 2 mM EGTA, 1 mM MgSO4, 3.7% formaldehyde, pH 7.4) then
incubated with the anti-NFPC antibody followed by an HRP-conjugated
secondary antibody and developed using diaminobenzidine (DAB) substrate.
Immunostained embryos were then dehydrated and processed by in situ
hybridization for TAF1. After in situ hybridization, embryos were embedded in
paraplast, serially sectioned into 10 μm sections, and photographed under a
bright-field microscope.
Cell-mixing assay
Embryos were injected into a single dorsal blastomere at the 32-cell stage; for
RNA injections, embryos were fixed and stained by immunofluorescence using
anti-His (Qiagen) or anti-myc epitope antibodies (DSHB), while, for morpholino
injections, embryos were co-injected with RNA encoding green fluorescent
protein (GFP). To quantify cell mixing, whole-mount embryos were viewed on a
Nikon M2Bio fluorescent dissecting scope, and fluorescent cells not in contact
with any other labeled cell were counted and an average obtained for 10–30
embryos for each RNA injected. The t test for independent groups was used to
determine the statistical difference between conditions (VassarStats.com).
Actin and β-catenin localization
For F-actin staining, stage 17 morpholino-injected embryos were fixed in
4% PFA, blocked in 5% goat serum/TBST (13.2 mM Tris Base, 73.2 mM Tris–
HCl, 600 mM NaCl, and 0.05% Tween-20) and incubated in 1 Unit of Oregon
Green phalloidin (Molecular Probes) for 1 h, washed in TBST, and viewed in
whole mount. For β-catenin localization, stage 17 embryos were fixed in Dents
Fix (80% methanol, 20% DMSO) overnight at −20°C. Embryos were then
rehydrated in 0.1 M sodium phosphate pH 6.3, saturated in 30% sucrose in 0.1
M sodium phosphate, infiltrated in 1:1 30% sucrose/phosphate buffer:O.C.T.
compound (Tissue Tek), and cryo-embedded in O.C.T. Sixteen-μm cryosections
were post-fixed with cold acetone, treated with 3 mg/ml NaBH4 in PBS, and
immunostained with β-catenin antibody (Sigma) followed by a Cy3-conjugated
secondary antibody (Jackson Immunochemical). Fluorescent whole-mount
embryos were imaged with a Zeiss AxioCam HRc digital camera and axiovision
software, while cryosections were imaged with a Nikon Microphot FXA
fluorescent microscope.
Convergent–extension assays
Embryos were injected into both dorsal blastomeres at the 4-cell stage with
either NFPCMO, TAF1MO, or CMO. Embryos were photographed at stages 15,
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average length/width ratio at each stage was calculated for 12–20 embryos for
each morpholino injected.Results
NFPC and TAF1 expression in the embryonic nervous system
To investigate the roles of NFPC and TAF1 in neurulation in
Xenopus, we first analyzed the expression of these genes in the
embryonic nervous system by in situ hybridization. In particular,
as the expression of TAF1 in the nervous system had not been
characterized, we sought to determine if TAF1 is expressed in
the nervous system as the neural tube forms. Results indicate that
TAF1 is expressed in a broad domain throughout the neural
ectoderm, starting at stage 13 (Figs. 1A–E). By stages 15–17,
TAF1 is highly expressed throughout the neural folds and neural
plate, with highest expression in the anterior neural plate. At later
stages, after the neural folds have closed (stage 20), TAF1 isFig. 1. Xenopus TAF1 and NFPC expression in the neural ectoderm. In situ hybridi
mount (A–I) or in cross section (J–O). At stage 13, TAF1 is expressed throughout the
TAF1 is expressed in the neural folds (nf). After neural tube closure, TAF1 is expr
forebrain (fb) (D, E). In contrast, at stage 17, NFPC expression is restricted to the tip
neural tube closure, NFPC is also expressed in the anterior neural tube, eye, and bran
with an antibody to NFPC (brown) demonstrates co-localization of NFPC and TAF1 a
is expressed throughout the neural plate, the somatic mesoderm (sm), and the inner la
neural folds (arrow in panel N) and the inner layer of the epidermal ectoderm prior t
ventral neural tube (O). Other abbreviations: nc, notochord; psm, presomitic mesodexpressed throughout the neural tube along the entire anterior–
posterior axis (Figs. 1D, M). TAF1 is also expressed in the inner
layer of the epidermal ectoderm starting after gastrulation,
although at lower levels than that observed in the neural
ectoderm (Fig. 1 and Heggem and Bradley, 2003). In
comparison, NFPC is expressed in a highly restricted domain
of cells at the tips of the neural folds, as well as in the inner layer
of the epidermal ectoderm (Bradley et al., 1998). NFPC
expression in the neural folds begins at stage 15, when the
neural folds first form, and is maintained throughout neurulation
until the neural folds have fused (Figs. 1F, G). Subsequent to
neural fold fusion, NFPC is expressed in a new location, in
presumptive motor neurons in the ventral neural tube (Fig. 1O).
While TAF1 has a broader expression domain in the neural
ectoderm, as compared to NFPC, both appear to be expressed in
an overlapping region of the neural folds (compare Figs. 1Cwith
F). To confirm this, we double stained embryos using an anti-
NFPC antibody followed by in situ hybridization for TAF1. As
shown in Fig. 1I, NFPC and TAF1 are co-expressed at the tips ofzation analysis for TAF1 (A–E, I–M) or NFPC (F–H, N, O), viewed in whole-
neural plate (np), with highest expression anteriorly. At stages 15 (B) and 17 (C),
essed throughout the neural tube (nt), in the eye (ey) brachial arches (ba), and
s of the neural folds (arrow in panels F and G) and in the ventral ectoderm. After
chial arches (H). (I) A stage 17 embryo stained by in situ for TAF1 (purple) and
t the tips of the neural folds (arrow). Sections through embryos reveal that TAF1
yer of the epidermal ectoderm (J–M), while NFPC is localized to the tips of the
o neural fold fusion. After the neural tube has closed, NFPC is expressed in the
erm.
Fig. 2. NFPC and TAF1 antisense morpholinos disrupt neural tube closure.
Embryos were co-injected with NFPCMO (A, D, G), TAF1MO (B, E, H) or
CMO (C, F, I) and nlacZ RNA, fixed at stage 17 (A–C), stage 20 (D–F), or stage
25 (G–I), and processed for β-galactosidase activity. In NFPCMO-injected
embryos, the neural folds were present at stage 17 (A), but by stage 20 (D) and
stage 25 (G), the neural folds have failed to fuse (arrow). Similarly, in embryos
injected with TAF1MO, the neural fold on the injected side formed (arrow in
panel B) but failed to fuse at stage 20 or 25 (E, H). In contrast, control-injected
embryos formed normal neural folds at stage 17 (C), which then fused at stage
20 (F) to form a normal tailbud stage embryo (I).
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TAF1 are expressed in an overlapping pattern in the neural folds
and are suggestive of roles in neurulation.
NFPC and TAF1 are required for proper neurulation
The restricted expression of NFPC in the neural folds
indicates a possible role for NFPC in mediating the adhesive
events required for neural fold formation and/or fusion.
Therefore, to investigate whether NFPC is involved in
neurulation, we disrupted NFPC expression in the neural folds
using an NFPC antisense morpholino (NFPCMO), previously
shown to deplete over 90% of NFPC protein in early embryos
(Heggem and Bradley, 2003). Accordingly, embryos were
injected with NFPCMO, together with LacZ RNA to act as a
tracer, into a single dorsal blastomere at the 8-cell stage. Injected
embryos were allowed to develop until stage 25, at which time
the neural folds have normally fused and the neural tube has
separated from the overlying ectoderm, and examined for neural
tube defects (NTDs). Results indicate that in 78% of NFPCMO-
injected embryos the neural tube failed to close, as compared to
embryos injected with a standard control morpholino (CMO)
(Figs. 2 and 3). The NTDs observed were characterized by
neural folds that appeared to form normally and extend towards
the midline, but which subsequently failed to fuse (Fig. 2).
Depending upon the location of the morpholino, the defects
occurred in both the anterior and posterior neural tube (Fig. 2 and
data not shown). Importantly, these defects were rescued by
overexpression of NFPCmRNA, indicating that the NTDs were
specifically due to NFPCMO inhibiting the expression of
endogenous NFPC (Fig. 3). This suggests that NFPC is required
for neural fold fusion along the entire AP axis, consistent with
the expression pattern of NFPC in the neural folds.
As TAF1 is also expressed in the neural ectoderm, we sought
to determine if TAF1 is required for proper neurulation. To
disrupt TAF1 function in the neural ectoderm, we utilized an
antisense TAF1morpholino (TAF1MO), previously shown to be
effective in depleting TAF1 protein in early embryos (Heggem
andBradley, 2003). Embryoswere injected with TAF1MO into a
single dorsal blastomere, allowed to develop until stage 25, and
analyzed for NTDs. Approximately 82% of TAF1MO-injected
embryos failed to close the neural tube, implying a requirement
for TAF1 in neurulation (Figs. 2 and 3). The defects caused by
TAF1MO in the neural tube were similar to those caused by
NFPCMO in that the neural folds form and elevate relatively
normally but failed to fuse along the midline (Fig. 2). To
demonstrate that the defects were specific to TAF1, we
attempted to rescue the embryos by ectopic expression of full-
length TAF1. Co-injecting TAF1MO together with full-length
TAF1 mRNA reduced the percentage of injected embryos with
NTDs from 82% to 46%. Furthermore, of those embryos that
still exhibited NTDs, the severity of these defects was also
reduced (Fig. 3). This indicates that the NTDs observed are due
to disruptions in TAF1 expression, rather than a nonspecific
inhibition of development, and confirms the importance of TAF1
in neurulation. Thus, TAF1 is also required for neural tube
closure, where it may cooperate with NFPC.NFPC and TAF1 dominant-negative constructs inhibit neural
tube formation
To confirm that NFPC and TAF1 are required for neural tube
formation, we next sought to inhibit NFPC and TAF1 protein
function using a dominant-negative approach. To disrupt NFPC
function, we utilized a construct that lacks the NFPC
extracellular domain (NFΔE), previously shown to disrupt
NFPC function in the epidermal ectoderm (Bradley et al., 1998).
To disrupt TAF1 expression, we created two TAF1 deletion
constructs, one encoding the N-terminal half of the protein
(TAF1ΔC) and the other, opposite construct, encoding solely
the C-terminal half of the protein (TAF1ΔN), both tagged with
an myc epitope. RNA encoding these deletion constructs was
injected into a single dorsal blastomere at the 8-cell stage, and
injected embryos were allowed to develop until stage 25 then
fixed for further analysis. Whole-mount immunochemical
Fig. 4. NFPC and TAF1 dominant-negative constructs disrupt neural tube
formation. Embryos were injected with RNA encoding NFΔE, TAF1ΔN, or
TAF1ΔC, along with nlacZ RNA, or were co-injected with NFΔE and NFPC
RNA or TAF1ΔN and TAF1 RNA then fixed at stage 25 and stained for β-
galactosidase activity. (A) The percentage of injected embryos with NTDs. Both
NFΔE and TAF1ΔN resulted in NTDs, the incidence of which was reduced by
co-expression of NFPC or TAF1, respectively. In contrast, ectopic expression of
TAF1ΔC resulted in few embryos with NTDs. (B–D) Representative embryos
from panel A. Compared to embryos injected with TAF1ΔC RNA (D) or nlacZ
RNA alone (E), embryos injected with NFΔE or TAF1ΔN RNA (arrows in
panels B and C) failed to close the anterior neural tube.
Fig. 3. Rescue of neural tube defects by ectopic expression of NFPC or TAF1.
(A) Embryos were injected with either NFPCMO or TAF1MO alone or were co-
injected with NFPCMO and NFPC RNA, or TAF1MO and TAF1 RNA, then
fixed at stage 25, and the percentage of injected embryos with neural tube
defects was determined. The percentage of embryos with NTDs was reduced
upon co-expression of NFPC or TAF1, respectively. (B–D) Examples of
rescued, morpholino-injected embryos from (A). The majority of embryos co-
injected with NFPCMO and NFPC mRNA appeared normal (C). While 54% of
TAF1MO and TAF1 mRNA-injected embryos appeared normal (D), 46% still
exhibited NTDs; however, the defects observed were greatly reduced in severity
(white arrows in panel E).
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antibody revealed that all constructs were properly expressed
in the neural ectoderm (data not shown).
The NFPC and TAF1 deletion constructs were examined for
their ability to perturb neural tube formation in embryos. As
summarized in Fig. 4A, approximately 66% of NFΔE-injected
embryos failed to close the neural tube, and these defects were
similar, though generally less severe, to those observed with
NFPCMO (Fig. 4B). Furthermore, the defects caused by NFΔE
were at least partially rescued by co-injection of wildtype NFPC
RNA, indicating that the NTDs were due to a loss in NFPC
function in the embryos. Similarly, approximately 72% of
embryos injected with TAF1ΔN RNA exhibited NTDs, as
compared to only 7% of TAF1ΔC RNA-injected embryos. The
NTDs observed with TAF1ΔN RNA were similar, though less
severe, than those caused by TAF1MO; in particular, the
anterior neural tube often failed to fuse, as compared to embryos
injected with RNA encoding TAF1ΔC or β-galactosidase alone
(Figs. 4C–E). This indicated that TAF1ΔN might be acting as a
dominant-negative, inhibiting the function of endogenous TAF1
in the neural ectoderm. To confirm this, we attempted to rescue
the NTDs caused by TAF1ΔN RNA by co-injecting wildtypeTAF1 RNA. Results demonstrate that co-injection of TAF1ΔN
and TAF1 RNA reduced the incidence of NTDs to 41% of
injected embryos. Furthermore, of the co-injected embryos that
still exhibited NTDs, the severity of these defects was
significantly reduced (data not shown). Thus, the NTDs
observed upon ectopic expression of TAF1ΔN were due to
the specific inhibition of TAF1 function in embryos. Collec-
tively, these dominant-negative experiments confirm the results
of the antisense morpholino experiments and indicate that
NFPC and TAF1 are both required for the proper formation and/
or fusion of the neural folds.
NFPC and TAF1 are required for the proper organization of
the neural folds
To investigate the nature of the NTDs observed when NFPC
or TAF1 is disrupted, embryos injected with NFPCMO,
TAF1MO, NFΔE, or TAF1ΔN were serially sectioned and
examined for altered neural fold and neural tube morphology.
As shown in Fig. 5, the neural defects are first observable at
stage 17, after the neural folds have formed but prior to neural
folds reaching the midline. In both NFPCMO- and TAF1MO-
injected embryos, the neural folds form but appear broadened
and disorganized on the injected side, as compared to the
uninjected side or to CMO-injected embryos. By stage 25, when
the neural tube has closed in control embryos, NFPCMO- or
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open. Embryos injected with the dominant-negative NFΔE or
TAF1ΔN constructs exhibited similar defects, where the neural
tube failed to close properly, although these defects were mostly
confined to the anterior neural tube (Figs. 4 and 5).
Interestingly, when either NFPC or TAF1 was disrupted in the
neural folds, the epidermal ectoderm was still able to migrate
over the neural ectoderm and by stage 25 covered the open
neural tube. In contrast, when NFPCMO or TAF1MO was
targeted to the epidermal ectoderm, resulting in epidermal
defects, the neural tube was still able to close normally (Figs. 5I
and J). In summary, these defects indicate that NFPC and TAF1
are essential for the proper morphology of the neural folds andFig. 5. NFPC and TAF1 function are required during neural fold formation and
neural tube closure. Embryos were co-injected with NFPCMO (A, B, I),
TAF1MO (C, D, J), CMO (E, F), or the dominant-negative constructs NFΔE (G)
and TAF1ΔN (H) and nLacZRNA, then fixed at stage 17 or stage 25, stained for
β-galactosidase activity, and sectioned. At stage 17, embryos injected with
NFPCMO (A) or TAF1MO (C) failed to form a normal neural fold on the
injected side. By stage 25, the neural tube failed to fuse, although the epidermal
ectoderm had reached the midline (B, D). Similarly, embryos injected with RNA
encoding NFΔE (G) or TAF1ΔN (I) failed to fuse the neural tube by stage 25. In
contrast, embryos injected with CMO (C, D) formed a normal neural fold and
neural tube, as did embryos in which NFPCMO or TAF1MO was targeted to the
epidermal ectoderm (I, J). Abbreviations: nc, notochord; nf, neural fold; nt,
neural tube; psm, presomitic mesoderm; sm, somite.for subsequent neural tube closure but may be less important for
the migration and fusion of the epidermal ectoderm.
NFPC and TAF1 mediate cell–cell adhesion in the neural
ectoderm
The disorganization of the neural folds in embryos in which
NFPC or TAF1 has been inhibited suggests a role for NFPC-
mediated adhesion in the proper formation and fusion of the
neural folds. While NFPC and TAF1 have previously been
shown to function in cell adhesion in the inner layer of the
epidermal ectoderm, a role for NFPC and TAF1 in cell adhesion
in the neural ectoderm has not been established. Therefore, to
determine if NFPC and TAF1 can function in cell–cell adhesion
during neurulation, we performed a cell-mixing assay for these
proteins in the neural ectoderm. Embryos at the 16-cell stage
were injected into a single dorsal blastomere with RNA
encoding NFPC tagged with a Histidine epitope (NFPC-HT)
then fixed at stage 15 and immunostained with an antibody
against the His epitope tag. As a negative control, embryos were
injected with RNA encoding solely a myc epitope (C-MT) and
immunostained with an antibody against c-myc. Embryos were
then examined, and the number of single cells in the neural
ectoderm, not in contact with another labeled cell, was counted.
C-MT-injected embryos exhibited extensive cell mixing at the
borders of a patch of cells expressing the myc epitope, while
embryos injected with NFPC-HT exhibited significantly fewer
single labeled cells (P V 0.0001), indicating that NFPC can
promote cell–cell adhesion and thereby suppress the normal cell
mixing that occurs in the neural ectoderm (Fig. 6). This ability
of NFPC to suppress cell mixing in the neural ectoderm was
comparable to that of the classical cadherin, E-cadherin.
To test whether TAF1 is required for NFPC-mediated cell
adhesion in the neural ectoderm, we investigated whether
TAF1MO or the dominant-negative TAF1ΔN could inhibit the
cell adhesion effect of NFPC, thereby increasing the cell mixing
that occurs in the neural ectoderm. Therefore, embryos were co-
injected with NFPC-HT RNA and either TAF1MO or TAF1ΔN-
MT RNA and analyzed for cell mixing as above. Results
demonstrate that either TAF1MO or TAF1ΔN-MT can
significantly inhibit NFPC-mediated cell adhesion in the neural
ectoderm, increasing the number of single cells at the borders of
a patch of expressing cells to levels comparable to that of
control embryos (P = 0.0001). In contrast, co-injection of
TAF1ΔN with E-cadherin did not inhibit the ability of E-
cadherin to suppress cell mixing, suggesting that inhibition of
TAF1 specifically disrupts NFPC-mediated cell adhesion in the
neural ectoderm. Altogether, these results demonstrate that
NFPC and TAF1 play interrelated roles in cell adhesion in the
neural folds and neural ectoderm.
NFPC and TAF1 are required for the apical localization of
F-actin
The cell-mixing assay indicates that NFPC and TAF1 can
function in cell adhesion in the neural ectoderm, and sections
through embryos in which NFPC or TAF1 was inhibited
Fig. 7. NFPCMO and TAF1MO alter the organization of the neural folds. (A–F)
Embryos were co-injected with NFPCMO (A, D), TAF1MO (B, E), or CMO
(C, F), and nlacZ RNA, fixed at stage 17, processed for β-galactosidase activity,
then stained with Oregon green-phalloidin to visualize F-actin, and viewed
under fluorescence (A–C) or bright field (D–F). While F-actin was localized to
the apical neural folds in CMO-injected embryos as well as on the uninjected
side in NFPCMO- and TAF1MO-injected embryos (closed arrows in panels
A–C), F-actin staining was lost at the tips of the neural folds on the injected
side (open arrows in panels A, B). (G–L) Embryos injected with antisense
morpholinos and examined by immunofluorescence for β-catenin localization at
stage 17. In control embryos and on the uninjected side of NFPCMO- and
TAF1MO-injected embryos, the neural folds formed normally. In contrast, the
neural fold on the NFPCMO- or TAF1MO-injected side formed abnormally.
High power photomicrographs revealed a disorganized neural epithelial on the
injected side of NFPCMO- and TAF1MO-injected embryos (arrowheads in
panels J, K) as compared to the typical columnar epithelia observed on the
uninjected side or in control embryos (long arrows in panels J–L). In all cases,
β-catenin was still localized to the cell membrane. In all photos, the injected side
is on the right. Abbreviations: nf, neural fold, nc, notochord, nt, neural tube.
Fig. 6. NFPC-mediated cell adhesion in the neural plate requires TAF1. (A)
Embryos at the 16-cell stage were injected into a single dorsal blastomere with
RNA encoding the indicated proteins or morpholinos then immunostained at
stage 15, and single labeled cells in the neural ectoderm not in contact with
another labeled cell were counted. As compared to control embryos injected
solely with RNA encoding c-myc (C-MT) or GFP, embryos injected with RNA
encoding NFPC-HT exhibited a reduced number of isolated cells in the neural
ectoderm. The ability of NFPC-HT to suppress cell mixing was abrogated by co-
injecting either the dominant-negative TAF1ΔN or TAF1MO, indicating that
NFPC requires TAF1 to promote cell adhesion. (B) Embryos injected as above
and stained by immunofluorescence for the histidine epitope tag to reveal NFPC-
HT (B and insert in panel C) or the myc epitope tag for TAF1ΔN-MT (C and D)
or C-MT (E). Arrows indicate isolated cells.
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was perturbed (Fig. 5). Taken together, these results suggest that
NFPC and TAF1 function to mediate the cell adhesion events
that organize the neural folds in advance of neural tube fusion.
Therefore, to investigate further the roles of NFPC and TAF1 in
the neural folds, NFPCMO- and TAF1MO-injected embryos
were analyzed for alterations in F-actin localization in the dorsal
neural fold cells. As previously reported (Haigo et al., 2003), in
uninjected embryos, F-actin was localized to the apical tips of
the neural folds at stage 17 (Fig. 7C). In contrast, NFPCMO-
and TAF1MO-injected embryos showed a marked decrease in
the localization of F-actin to the apical neural folds on the
injected side (Figs. 7A, B). This indicates that NFPC-mediatedcell adhesion is required for the proper localization of F-actin to
the tips of the neural folds during neurulation.
To determine whether other morphological changes occur in
the dorsal neural folds when NFPC or TAF1 are inhibited,
NFPCMO- and TAF1MO-injected embryos were immunos-
tained for β-catenin, a marker of classical cadherin containing
adherens junctions. As shown in Fig. 7, the morphology of the
neural folds in NFPCMO- and TAF1MO-injected embryos was
altered. In particular, the neural fold on the injected side was
broadened, and high power examination reveals cells that had
lost their columnar morphology and appeared rounded and
disorganized. In contrast, the neural fold on the uninjected side,
as well as in CMO-injected embryos, exhibited a typical
columnar epithelial organization. However, β-catenin was still
Fig. 8. NFPC and TAF1 are required for convergent–extension after the neural
folds have formed. (A) Embryos were injected with NFPCMO, TAF1MO, or
CMO into both dorsal blastomeres at the 4-cell stage, and average length/width
ratios of the AP axis were obtained at the indicated stages. NFPCMO and
TAF1MO did not affect CE until stage 22. (B–D) As compared to the CMO,
NFPCMO and TAF1MO-injected embryos at the equivalent of stage 25
exhibited a shortened AP axis.
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embryos, signifying that classical cadherin-based cell adhesion
was not perturbed by disrupting NFPC or TAF1. These results
indicate that NFPC and TAF1 are required for the proper
morphology and cytoskeletal organization of the neural fold
cells prior to neural fold fusion and suggest that this role is
independent of classical cadherins.
Involvement of NFPC and TAF1 in convergent–extension
The above results demonstrate roles for NFPC and TAF1 in
cell adhesion in the neural ectoderm, where they function to
organize the dorsal neural folds prior to neural fold fusion. As it
is known that CE plays an important role throughout
neurulation, to shape the neural plate, elevate the neural folds,
and elongate the neural axis, it is possible that NFPC and TAF1
may participate in CE during neurulation. Therefore, we next
sought to determine if NFPC and TAF1 participate in CE in the
neural ectoderm and, if so, whether NFPC and TAF1 participate
in the early CE movements that shape the neural plate and
elevate the neural folds or, alternatively, whether they are
involved in later events in CE, after neural fold formation and
fusion, as the neural tube elongates along the A–P axis. As a
measure of the extent of CE, we injected NFPCMO or
TAF1MO into both dorsal blastomeres at the 4-cell stage and
then determined the length and width of the neural ectoderm in
injected embryos at stages 15, 19, 22 and 25. As shown in Fig.
8, average length/width ratios for NFPMO-, TAF1MO-, and
CMO-injected embryos were not significantly different at
stages 15 and 19, suggesting that CE of the neural ectoderm
was not altered at these stages. However, beginning at stage 22,
NFPCMO- and TAF1MO-injected embryos were shorter in
length, and their length/width ratios were significantly less, as
compared to CMO-injected embryos. These results suggest that
NFPC and TAF1 do not play significant roles in the early CE
events that initially shape the neural plate and form the caudal
neural folds, but these molecules may participate in later CE
events, as the neural folds meet and fuse, and the neural tube
elongates along the anterior–posterior axis.
Discussion
The formation of the vertebrate neural tube is a complex
process requiring extensive cell–cell interactions and cell
movements. Several proteins are known to play important
roles in forming the neural tube, including transcription factors
involved in neural induction, members of the planar cell polarity
pathway, as well as actin binding proteins. Results presented
here demonstrate that cell–cell adhesion, as mediated by NFPC
and TAF1, also plays crucial roles in the process of neurulation,
contributing to the cell interactions required to organize the
neural folds. NFPC is homologous to human and mouse
PCDH7 and is a member of the recently described δ-
protocadherin subfamily (Vanhalst et al., 2005). In mice,
PCDH7 is expressed in restricted domains in the embryonic
and adult retina and brain, where it is proposed to regulate
regionalization and functional differentiation of these structures(Yoshida et al., 1998; Vanhalst et al., 2005). We provide here the
first evidence that NFPC and its associated factor TAF1 are
required for the proper formation of the neural tube in Xenopus,
where they function to mediate cell–cell adhesion and cell
morphology within the neural folds. These results suggest novel
functions for protocadherins and their associated factors in
vertebrate neural development.
NFPC and TAF1 in neural fold fusion
The expression patterns of NFPC and TAF1 in the neural
folds suggested a role in neurulation, which was confirmed by
experiments designed to disrupt NFPC or TAF1 in the neural
ectoderm. Evidence that NFPC is required for proper
neurulation was demonstrated by a failure of the neural
folds to close when NFPC was inhibited, either by the
dominant-negative NFΔE construct or the antisense NFPC
morpholino. Similarly, disruptions in TAF1, by either the
antisense TAF1MO or by a dominant-negative construct
(TAF1ΔN), also resulted in NTDs. In general, the NTDs
observed when NFPC or TAF1 was disrupted using an
antisense morpholino approach were similar but more severe
than those observed when the dominant-negative constructs
were ectopically expressed. This was likely due to the
increased stability of morpholinos as compared to injected
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disrupting NFPC or TAF1 was evidenced by the ability of
RNA encoding wildtype NFPC or TAF1 to rescue the
respective NTDs. In particular, the defects caused by
NFPCMO were almost completely rescued by RNA encoding
wildtype NFPC, while TAF1MO was only partially rescued
by TAF1 RNA, although the remaining NTDs were reduced
in severity (Fig. 3D). Unfortunately, an increase in the amount
of TAF1 RNA relative to TAF1MO (or TAF1ΔN) resulted in
exogastrulation, limiting the amount of TAF1 RNA that could
be injected in these rescue experiments (data not shown).
Interestingly, TAF1 RNA could not rescue the defects caused
by NFPCMO; conversely, ectopic expression of NFPC RNA
did not rescue the TAF1MO-induced NTDs, indicating that
the depletion of either protein is sufficient to disrupt
neurulation (data not shown).
The most likely explanation for the NTDs observed when
either NFPC or TAF1 expression is inhibited is that these two
proteins participate in cell–cell adhesion in the neural folds.
That NFPC can function in cell adhesion in the embryonic
nervous system is demonstrated by the cell-mixing assay (Fig.
6). In this assay, the ability of NFPC to promote cell adhesion
was inhibited by the dominant-negative TAF1ΔN. Together
with our previous results showing that TAF1 can bind the
cytoplasmic domain of NFPC (Heggem and Bradley, 2003),
these data suggest that NFPC requires TAF1 to function as a cell
adhesion molecule in the neural folds. Interestingly, ectopic
expression of TAF1 alone suppressed cell mixing, albeit to a
lesser degree than NFPC. A possible explanation for this effect
is that ectopic TAF1 may promote the assembly or stability of
nascent adhesion complexes. In this scenario, disruptions in
TAF1 may then result in a loss in NFPC protein that is stably
localized to the plasma membrane. In fact, our preliminary
observations suggest that this may be the case; when TAF1 was
disrupted, immunolocalization of NFPC at the membrane
appeared reduced, with a corresponding increase in cytoplasmic
staining (Fig. 6C insert and data not shown).
As neurulation is a complex process, the question arises as
to when NFPC and TAF1 regulated cell adhesion is required.
Given the restricted expression of NFPC to a small domain of
cells along the dorsal neural folds, it was initially thought that
NFPC might mediate the fusion of the apposing neural folds,
one of the last events to occur in neurulation. However,
results presented here indicate that NFPC and TAF1 are
required earlier in neurulation as the neural folds are being
shaped. Firstly, disrupting NFPC or TAF1 expression resulted
in alterations in the morphology of the dorsal neural folds on
the injected side, and this was apparent by stage 17, prior to
the apposing neural folds contacting one another. Secondly,
concomitant with the altered shape, the cytoskeletal organi-
zation of the cells in the dorsal neural folds was disrupted, as
evidenced by altered F-actin localization, and cell–cell
interactions within the neural folds were perturbed as cells
lost their columnar epithelial morphology and became more
disorganized. Thus, NFPC and TAF1 are required to maintain
the columnar epithelial integrity of the dorsal neural folds,
which may then fuse by NFPC-mediated adhesion or someother adhesive mechanism. Interestingly, the defects observed
when NFPC or TAF1 were disrupted ranged from an open
neural tube along the entire AP axis to a failure of just the
anterior neural folds to close (Figs. 2 and 4). The more
extensive defects are consistent with NFPC and TAF1 playing
important roles in the organization of the neural folds along
the entire AP axis.
That cadherin-based cell adhesion can control cell shape has
been demonstrated in other systems (Hayashi and Carthew,
2004; Carthew, 2005; Lecuit, 2005). Cell–cell adhesion can
control the extent to which neighboring cells interact as well as
their cytoskeletal architecture. Thus, a loss in NFPC-mediated
cell adhesion is likely directly responsible for the changes in cell
morphologies and actin localization in the neural folds that we
observe here. What remains unknown is the mechanism by
which NFPC and/or TAF1 are linked to the actin cytoskeleton.
One possibility is that either protein may interact with the actin-
binding protein Shroom. Shroom is required for proper
neurulation in vertebrates, where it is responsible for the
localization of F-actin to the apices of the neural folds, creating
the wedge-shaped cells that bend the neural tube toward the
midline (Hildebrand and Soriano, 1999; Haigo et al., 2003).
Disruptions in Shroom lead to a loss of F-actin staining at the
apices as well as a loss in the hinge point cells, a phenotype
similar to that observed when NFPC and TAF1 are disrupted
(Fig. 7). Whether NFPC and/or TAF1 interact with Shroom in
vivo is currently under study.
In the chick embryo, it has been reported that the
migration of the epidermal ectoderm adjacent to the neural
plate helps push the neural folds towards the midline (Alvarez
and Schoenwolf, 1992). As we have previously shown that
both NFPC and TAF1 are required for formation of the
epidermis in Xenopus, an alternative explanation for the
NTDs is that, by altering NFPC or TAF1 function, the neural
tube fails to close due to disruptions in the epidermal
ectoderm. However, the NTDs we observed occurred only
when the NFPC or TAF1 morpholinos (or dominant-negative
constructs) were targeted to the neural folds and neural
ectoderm. In particular, when NFPC or TAF1 was targeted to
the epidermal ectoderm, the neural tube still closed, even
though the epidermis was disrupted (Figs. 5I and J).
Furthermore, when morpholinos or dominant-negative con-
structs were targeted to the neural folds and the neural tube
failed to close, the epidermal ectoderm was still able to
migrate and cover the open neural tube (Figs. 5B, D, G, H).
In particular, when NFPC was disrupted, the dorsal epidermis
appeared relatively normal, but when TAF1 was disrupted,
the dorsal epidermis was present but often abnormally folded.
While not ruling out a role for the epidermis in neurulation,
our results suggest that neural tube closure requires the
function of NFPC and TAF1 in the neural folds. Furthermore,
these results indicate that fusion of the neural ectoderm and
the epidermal ectoderm are two separate events, as previously
proposed (Lawson and England, 1998). The subsequent
differentiation of the dorsal epidermis may then require
NFPC or TAF1, consistent with previously published results
(Heggem and Bradley, 2003).
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roles ascribed to it. TAF1 is a component of the INHAT
(inhibitor of acetyltransferases) complex, which binds histones
and blocks acetylation. TAF1 also interacts with, and promotes
the activity of, neuronal Cdk5 kinase, suggesting that another
function of TAF1 is to modulate protein phosphorylation. TAF1
has been shown to localize to both the cytoplasm and the
nucleus in several cell types, and our previous results
demonstrated that a subset of TAF1 protein is found at the
cell membrane where it can interact with NFPC (Heggem and
Bradley, 2003). This suggests that another mechanism by which
TAF1 may act in the neural folds is as a link between NFPC-
mediated cell adhesion and changes in protein phosphorylation
and/or histone acetylation. Either of these scenarios could lead
to changes in transcriptional levels in the neural folds in
response to cell–cell adhesion. It is worth noting that the
antisera to NFPC, which was generated against the cytoplasmic
domain, immunolabels not only the ectodermal cell membranes
in embryos, but also the nucleus (Fig. 1I and data not shown).
Whether this indicates that the cytoplasmic domain of NFPC
can also translocate to the nucleus is not known. However,
several cadherin family members are known to undergo
proteolysis to release their intercellular domains; furthermore,
the intercellular domains of Pcdhγ protocadherins and human
protocadherin Fat1 have been shown to translocate to the
nucleus following proteolytic processing (Marambaud et al.,
2002, 2003; Haas et al., 2005; Hambsch et al., 2005; Magg et
al., 2005). Whether transcriptional changes occur in the neural
folds in response to changes in NFPC and TAF1 mediated cell
adhesion is an interesting possibility that is currently under
investigation.
TAF1 exhibits a broader expression pattern in both the
anterior and caudal neural plate, as compared to NFPC (Fig. 1).
This suggests that TAF1 may have additional roles in neural
development that are independent of NFPC. In fact, preliminary
results suggest that this is indeed the case, at least for the
anterior neural tube. When TAF1 is disrupted in the anterior
neural plate, the defects are often very severe, resulting in the
loss of anterior structures (Fig. 8 and data not shown). In this
regard, TAF1 may interact with other protocadherins in the
anterior neural plate. One possible candidate is XFmi, a
homolog of the 7-transmembrane protocadherin Flamingo/
Celsr, which is expressed in the anterior neural plate in frogs
(Morgan et al., 2003). In contrast, in the caudal neural plate,
disruptions in NFPC or TAF1 result in similar defects, despite
the fact that TAF1 is expressed more broadly. It is possible that,
within the caudal neural plate, TAF1 may also function
independent of cell adhesion, for example, to regulate
transcription as a component of INHAT or Cdk5 kinase.
Preliminary results indicate that the expression of Sox2 and
SoxD, two genes involved in neural induction, is not altered
when either NFPC or TAF1 is disrupted (data not shown).
While this suggests that neither NFPC nor TAF1 has roles in the
initial specification of the neural ectoderm, we cannot rule out a
transcriptional role for TAF1 later in neural development. The
ability of TAF1ΔN to function as a dominant-negative, as
opposed to TAF1ΔC, suggests that TAF1 may have separatedomains that interact with NFPC versus binding to other factors,
and this is currently under investigation.
NFPC and TAF1 may participate in convergent–extension after
the neural folds are formed
Several other molecules that function in vertebrate neurula-
tion are components of the PCP pathway and are required for
the CE movements that form the neural folds (Kibar et al., 2001;
Hamblet et al., 2002; Murdoch et al., 2003). For example,
Xenopus Dishevelled and Strabismus are two PCP genes that
are involved in the early CE events that shape the neural plate,
and disruptions in the expression of either gene result in
embryos in which the neural folds fail to elevate properly, as
well as a severely shortened AP axis. These defects in CE in the
neural plate can be observed early, at stage 15, due to the
broadened expression of genes involved in neural induction as
well as the subsequent shortening of the neural axis (Goto and
Keller, 2002; Wallingford and Harland, 2002). While inhibition
of NFPC or TAF1 resulted in a failure of the neural tube to
close, the neural folds still elevated relatively normally,
indicating that initial CE events were not altered. In addition,
when NFPC or TAF1 was inhibited, there was no obvious
difference in the expression of neural induction genes at stage
15 (data not shown). Furthermore, while disruptions in NFPC
and TAF1 can lead to a shortened AP axis, this was not evident
until stages 22–25, after neural tube closure and much later than
that observed when Xenopus PCP genes were disrupted. This
suggests that NFPC and TAF1 are not involved in the CE
processes that shape the neural plate and elevate the neural folds
but may participate in CE later as the neural folds reach the
midline and subsequently fuse. This is consistent with our
results demonstrating a role for NFPC and TAF1 in organizing
the dorsal neural folds just prior to fusion. Alternatively, NFPC
and TAF1 may function in CE after neural tube closure as the
neural tube cells sort into a single-layered columnar epithelia. In
fact, at stage 25, NFPC is expressed in presumptive motor
neurons, while TAF1 remains expressed throughout the neural
tube (Fig. 1), suggesting additional roles within the nascent
neural tube. One mechanism by which NFPC and TAF1 could
interact with the PCP pathway is via protein phosphatase 2A
(PP2A). TAF1 can interact with, and inhibit the activity of,
PP2A; and PP2A has been shown to participate in PCP in both
Drosophila and zebrafish (Li et al., 1996; Hannus et al., 2002).
However, at this point, we cannot rule out the possibility that
NFPC and TAF1 have an indirect role in regulating later CE
events. Specifically, an alternative explanation for the shortened
AP axis observed when NFPC or TAF1 was disrupted is that the
neural tube cannot properly extend along the anterior–posterior
axis if it has not properly closed.
Cadherin family members in neurulation
Other cadherin family members that participate in neurula-
tion include the protocadherin Flamingo/Celsr1 and the
classical cadherin N-cadherin. Flamingo/Celsr1 has been
shown to function in the PCP pathway, and, when Flamingo/
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to those observed when other PCP pathway members were
disrupted, namely, a failure of the caudal neural tube to close
and a shortened AP axis (Curtin et al., 2003). In contrast, N-
cadherin functions both to maintain the integrity of the neural
ectoderm and is also involved (along with E-cadherin) in the
segregation of the neural ectoderm from the epidermal ectoderm
(Detrick et al., 1990; Kintner, 1992; Levine et al., 1994). NFPC,
in contrast, appears to play a more restricted role during
neurulation, being required to maintain the morphology and
cell–cell interactions within a subgroup of cells in the neural
folds as the neural folds meet and fuse along the dorsal midline.
β-catenin, a necessary co-factor of classical cadherins (Wheel-
ock and Johnson, 2003; Nelson and Nusse, 2004), was still
found at the cell membrane when NFPC or TAF1 expression
was inhibited (Fig. 7). This suggests that classical cadherins are
still functioning within the neural plate and neural tube when
NFPC is disrupted. These results indicate that protocadherins
and classical cadherins, while related to each other, play distinct
roles during the morphogenesis of the vertebrate neural tube.Acknowledgments
We thank P. Thorsen for technical assistance and F. Lefcort
and J. Bononi for advice. This study was supported by grants
from NSF (0416213) and NCRR COBRE (RR15583).References
Alvarez, I.S., Schoenwolf, G.C., 1992. Expansion of surface epithelium
provides the major extrinsic force for bending of the neural plate. J. Exp.
Zool. 261, 340–348.
Angst, B.D., Marcozzi, C., Magee, A.I., 2001. The cadherin superfamily:
diversity in form and function. J. Cell Sci. 114, 629–641.
Borchers, A., David, R., Wedlich, D., 2001. Xenopus cadherin-11 restrains
cranial neural crest migration and influences neural crest specification.
Development 128, 3049–3060.
Bradley, R.S., Espeseth, A., Kintner, C., 1998. NF-protocadherin, a novel
member of the cadherin superfamily, is required for Xenopus ectodermal
differentiation. Curr. Biol. 8, 325–334.
Carthew, R.W., 2005. Adhesion proteins and the control of cell shape. Curr.
Opin. Genet. Dev. 15, 358–363.
Colas, J.F., Schoenwolf, G.C., 2001. Towards a cellular and molecular
understanding of neurulation. Dev. Dyn. 221, 117–145.
Curtin, J.A., Quint, E., Tsipouri, V., Arkell, R.M., Cattanach, B., Copp, A.J.,
Henderson, D.J., Spurr, N., Stanier, P., Fisher, E.M., Nolan, P.M., Steel, K.P.,
Brown, S., Gray, I.C., Murdoch, J.N., 2003. Mutation of Celsr1 disrupts
planar polarity of inner ear hair cells and causes severe neural tube defects in
the mouse. Curr. Biol. 13, 1129–1133.
Davidson, L.A., Keller, R.E., 1999. Neural tube closure in Xenopus laevis
involves medial migration, directed protrusive activity, cell intercalation,
and convergent extension. Development 126, 4547–4556.
De Robertis, E.M., Kuroda, H., 2004. Dorsal–ventral patterning and neural
induction in Xenopus embryos. Annu. Rev. Cell Dev. Biol. 20, 285–308.
Detrick, R.J., Dickey, D., Kintner, C.R., 1990. The effects of N-cadherin
misexpression on morphogenesis in Xenopus embryos. Neuron 4, 493–506.
Elul, T., Koehl, M.A.R., Keller, R., 1997. Cellular mechanism underlying neural
convergent extension in Xenopus laevis embryos. Dev. Biol. 191, 243–258.
Frank, M., Kemler, R., 2002. Protocadherins. Curr. Opin. Cell Biol. 14,
557–562.Goodwin, M., Yap, A.S., 2005. Classical cadherin adhesion molecules:
coordinating cell adhesion, signaling and the cytoskeleton. J. Mol. Med.
35, 839–844.
Goto, T., Keller, R., 2002. The planar cell polarity gene Strabismus regulates
convergence and extension and neural fold closure in Xenopus. Dev. Biol.
247, 165–181.
Gumbiner, B.M., 2005. Regulation of cadherin-mediated adhesion in morpho-
genesis. Nat. Rev., Mol. Cell Biol. 6, 622–634.
Haas, I.G., Frank, M., Veron, N., Kemler, R., 2005. Presenilin-dependent
processing and nuclear function of γ-protocadherins. J. Biol. Chem. 280,
9313–9319.
Haigo, S.L., Hildebrand, J.D., Harland, R.M., Wallingford, J.B., 2003. Shroom
induces apical constriction and is required for hingepoint formation during
neural tube closure. Curr. Biol. 13, 2125–2137.
Hamblet, N.S., Lijam, N., Ruiz-Lozano, P., Wang, J., Yang, Y., Chien, K.R.,
Sussuman, D.J., Wynshaw-Boris, A., 2002. Dishevelled-2 is essential for
cardiac outflow tract development, somite segmentation and neural tube
closure. Development 129, 5827–5838.
Hambsch, B., Grinevich, V., Seeburg, P.H., Schwarz, M.K., 2005. γ-
protocadherins: presenilin-mediated release of C-terminal fragment pro-
motes locus expression. J. Biol. Chem. 280, 15888–15897.
Hannus, M., Feiguin, F., Heisenberg, C.P., Eaton, S., 2002. Planar cell
polarization requires Widerborst, a B' regulatory subunit of protein
phosphatase 2A. Development 129, 3423–3503.
Harland, R.M., 1991. In situ hybridization: an improved whole-mount method
for Xenopus embryos. Methods Cell Biol. 36, 685–695.
Hayashi, T., Carthew, R.W., 2004. Surface mechanics mediate pattern formation
in the developing retina. Nature 431, 647–652.
Heggem, M.A., Bradley, R.S., 2003. The cytoplasmic domain of Xenopus NF-
protocadherin interacts with TAF1/Set. Dev. Cell 4, 419–429.
Hildebrand, J.D., Soriano, P., 1999. Shroom, a PDZ domain-containing actin-
binding protein, is required for neural tube morphogenesis in mice. Cell 99,
485–497.
Kibar, Z., Vogan, K.J., Grouix, N., Justice, M.J., Underhill, D.A., Gros, P.,
2001. Ltap, a mammalian homolog of Drosophila Strabismus/Van Gogh,
is altered in the mouse neural tube mutant Loop-tail. Nat. Genet. 28,
251–255.
Kintner, C., 1992. Regulation of embryonic cell adhesion by the cadherin
cytoplasmic domain. Cell 69, 225–236.
Koch, A.W., Bozic, D., Pertz, O., Engel, J., 1999. Homophilic adhesion by
cadherins. Curr. Opin. Struct. Biol. 9, 275–281.
Lawrence, N., Morel, V., 2003. Dorsal closure and convergent extension: two
polarised morphogenetic movements controlled by similar mechanisms?
Mech. Dev. 120, 1385–1393.
Lawson, A., England, M.A., 1998. Neural fold fusion in the cranial region of the
chick embryo. Dev. Dyn. 212, 473–481.
Lecuit, T., 2005. Adhesion remodeling underlying tissue morphogenesis. Trends
Cell Biol. 15, 34–42.
Lele, Z., Folchert, A., Concha, M., Rauch, G.J., Geisler, R., Rosa, F., Wilson,
S.W., Hammerschmidt, M., Bally-Cuif, L., 2002. parachute/n-cadherin is
required for morphogenesis and maintained integrity of the zebrafish neural
tube. Development 129, 3281–3294.
Levine, E., Lee, C.H., Kintner, C., Gumbiner, B.M., 1994. Selective disruption
of E-cadherin function in early Xenopus embryos by a dominant negative
mutant. Development 120, 901–909.
Li, M., Makkinje, A., Damuni, Z., 1996. The myeloid leukemia-associated
protein SET is a potent inhibitor of protein phosphatase 2A. J. Biol. Chem.
271 (19), 11059–11062.
Luo, M., Ferreira-Cornwell, C., Baldwin, H.S., Kostetskii, I., Lenox, J.M.,
Lieberman, M., Radice, G.L., 2001. Rescuing the N-cadherin knockout by
cardiac-specific expression of N- or E-cadherin. Development 128,
459–469.
Magg, T., Schreiner, D., Solis, G.P., Bade, E.G., Hofer, H.W., 2005. Processing
of the human protocadherin Fat1 and translocation of its cytoplasmic domain
to the nucleus. Exp. Cell Res. 307 (1), 100–108.
Marambaud, P., Shioi, J., Serban, G., Georgakopoulos, A., Sarner, S., Nagy, V.,
Baki, L., Wen, P., Efthimiopoulos, S., Shao, Z., Wisniewski, T., Robakis,
N.K., 2002. A presenilin-1/γ-secretase cleavage releases the E-cadherin
181D. Rashid et al. / Developmental Biology 291 (2006) 170–181intracellular domain and regulates disassembly of adherens junctions.
EMBO J. 21, 1948–1956.
Marambaud, P., Wen, P.H., Dutt, A., Shioi, J., Takashiima, A., Siman, R.,
Robakis, N.K., 2003. A CBP binding transcriptional repressor produced by
the PS1/ε-cleavage of N-cadherin is inhibited by PS1 FAD mutations. Cell
114, 635–645.
McNeill, H., 2002. Planar polarity: location, location, location. Curr. Biol. 12,
R449–R451.
Morgan, R., El-Kadi, A., Theolki, C., 2003. Flamingo, a cadherin-type
receptor involved in the Drosophila planar polarity pathway, can block
signaling via the canonical wnt pathway in Xenopus laevis. Int. J. Dev.
Biol. 47, 245–252.
Murdoch, J.N., Henderson, D.J., Doudney, K., Gaston-Massuet, C., Phillips,
H.M., Paternotte, C., Arkell, R., Stanier, P., Copp, A.J., 2003. Disruption
of scribble (Scrb 1) causes severe neural tube defects in the circletail
mouse. Hum. Mol. Genet. 12 (2), 87–98.
Nakagawa, S., Takeichi, M., 1995. Neural crest cell–cell adhesion controlled by
sequential and subpopulation-specific expression of novel cadherins.
Development 121 (5), 1321–1332.
Nakagawa, S., Takeichi, M., 1998. Neural crest emigration from the neural tube
depends on regulated cadherin expression. Development 125 (15), 2963–2971.
Nelson, W.J., Nusse, R., 2004. Convergence of Wnt, β-catenin, and cadherin
pathways. Science 303, 1483–1487.
Poznanski, A., Minsuk, S., Stathopoulos, D., Keller, R., 1997. Epithelial cell
wedging and neural trough formation are induced planarly in Xenopus,
without persistent vertical interactions with mesoderm. Dev. Biol. 189,
256–269.
Price, S.R., De Marco Garcia, N.V., Ranscht, B., Jessell, T.M., 2002. Regulation
of motor neuron pool sorting by differential expression of type II cadherins.
Cell 109, 205–216.
Radice, G., Rayburn, H., Matsunami, H., Knudsen, K., Takeichi, M., Hynes, R.,1997. Developmental defects in mouse embryos lacking N-cadherin. Dev.
Biol. 181 (1), 64–78.
Redies, C., 2000. Cadherins in the central nervous system. Prog. Neurobiol. 61,
611–648.
Tepass, U., 1999. Genetic analysis of cadherin function in animal morphogen-
esis. Curr. Opin. Cell Biol. 11, 540–548.
Tepass, U., Truong, K., Godt, D., Ikura, M., Peifer, M., 2000. Cadherins in
embryonic and neural morphogenesis. Nat. Rev., Mol. Cell Biol. 1, 91–100.
Turner, D.L., Weintraub, H., 1994. Expression of acheate–scute homolog 3 in
Xenopus embryos converts ectodermal cells to a neural fate. Genes Dev. 8,
1434–1447.
Vanhalst, K., Kools, P., Staes, K., van Roy, F., Redies, C., 2005. δ-
protocadherins: a gene family expressed differentially in the mouse brain.
Cell. Mol. Life Sci. 62, 01–13.
Vleminckx, K., Kemler, R., 1999. Cadherins and tissue formation: integrating
adhesion and signaling. BioEssays 21, 211–220.
Wallingford, J.B., Harland, R.M., 2002. Neural tube closure requires
Dishevelled-dependent convergent extension of the midline. Development
129, 5815–5825.
Wallingford, J.B., Fraser, S.E., Harland, R.M., 2002. Convergent extension: the
molecular control of polarized cell movement during embryonic develop-
ment. Dev. Cell 2, 695–706.
Wheelock, M.J., Johnson, K.R., 2003. Cadherins as modulators of cellular
phenotype. Annu. Rev. Cell Dev. Biol. 19, 207–235.
Yoshida, K., Yoshitomo-Nakagawa, K., Seki, N., Sasaki, M., Sugano, S., 1998.
Cloning, expression analysis, and chromosomal localization of BH-
protocadherin (PCDH7), a novel member of the cadherin superfamily.
Genomics 49, 458–461.
Zohn, I.E., Chesnutt, C.R., Niswander, L., 2003. Cell polarity pathways
converge and extend to regulate neural tube closure. Trends Cell Biol. 13 (9),
451–454.
